Picture of Ion Beam Applications SA logo

IBAB — Ion Beam Applications SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

IBA rises on new Rhodotron accelerator contract

** Shares of Belgian radiation therapy and
radiopharmaceuticals equipment company Ion Beam Applications
 IBAB.BR  up 6% after it announces a contract with Benebion for
a Rhodotron accelerator in Mexico
    ** The contract size, typically around 8.5 mln euros to 11
mln euros ($8.98 mln to $11.62 mln), shows positive commercial
momentum for IBA - ING analyst David Vagman 
    ** Order intake development is yet to be seen to fully
comprehend the situation - brokerage
    ** KBC Securities sees returning momentum for IBA's
industrial solutions, pointing to the second Rhodotron contract
signed in November
    ** KBC keeps its "buy" rating due to revived demand in
industrial solutions and underlying radiopharma growth trends
    ** IBA shares are leading the Belgium Mid Cap index  .BELMC 
    
($1 = 0.9466 euros)

 (Reporting by Gianluca Lo Nostro)
 ((gianluca.lonostro@thomsonreuters.com;))

Recent news on Ion Beam Applications SA

See all news